UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040247
Receipt number R000045859
Scientific Title Miyagi Karoshi Prevention Study for Teachers
Date of disclosure of the study information 2020/04/27
Last modified on 2022/10/31 14:40:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Miyagi Karoshi Prevention Study for Teachers

Acronym

Miyagi Karoshi Prevention Study for Teachers

Scientific Title

Miyagi Karoshi Prevention Study for Teachers

Scientific Title:Acronym

Miyagi Karoshi Prevention Study for Teachers

Region

Japan


Condition

Condition

general school workers

Classification by specialty

Cardiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to exmine the hypothesis if intervention according to home blood pressure category is effective to reduce cardiovascular risk in school workers associated mith microalbuminuria

Basic objectives2

Others

Basic objectives -Others

cross-sectional analysis to examine the relationship between work stress, work conditions, others and cardiovascular risks or albuminuria

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

frequency of microalbuminuria 1 year after intervention

Key secondary outcomes

Urine albumin excretion 1 year after intervention


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Subjects with home blood pressures 135 mm Hg or over for sytolic or 85 mm Hg or over for diastolic recieve lifestyle guidance and will be encouraged to consult doctor.
Subjects with home blood pressures 125 to 134 mm Hg for sytolic and 80 to 84mm Hg for diastolic will receive lifestyle guidance.
Subjects with home blood pressures below 125 and 80 mm Hg receive lifestyle guidance according to their metabolic risks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

workers with microalbuminuria

Key exclusion criteria

workers with macroalbuminuria
female workers dring menstrual period

Target sample size

180


Research contact person

Name of lead principal investigator

1st name MASANORI
Middle name
Last name MUNAKATA

Organization

Tohoku Rosai Hospital

Division name

Research Center for lifestyle-related disease

Zip code

981-8563

Address

3-21, Dainohara 4, Aobaku, Sendai

TEL

022-275-1111

Email

munakata@tohokuh.johas.go.jp


Public contact

Name of contact person

1st name MASANORI
Middle name
Last name MUNAKATA

Organization

Tohoku Rosai Hospital

Division name

Research Center for lifestyle-related disease

Zip code

981-8563

Address

3-21, Dainohara 4, Aobaku, Sendai

TEL

022-275-1111

Homepage URL


Email

munakata@tohokuh.johas.go.jp


Sponsor or person

Institute

Japan Organization of Occupational Health and Safety

Institute

Department

Personal name



Funding Source

Organization

Japan Organization of Occupational Health and Safety

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku Rosai Hospital

Address

3-21, Dainohara 4, Aobaku, Sendai

Tel

022-275-1111

Email

soumu.shomu1@tohokuh.johas.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

151

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 10 Month 01 Day

Date of IRB

2018 Year 08 Month 20 Day

Anticipated trial start date

2020 Year 10 Month 21 Day

Last follow-up date

2021 Year 12 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

INTERNAL MEDICINE ADVANCE PUBLICATION


Management information

Registered date

2020 Year 04 Month 27 Day

Last modified on

2022 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045859


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name